Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ISM”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Not applicableStudy completedNCT05480046
What this trial is testing

Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse

Who this might be right for
Schizophrenia
Rovi Pharmaceuticals Laboratories 275
Not applicableLooking for participantsNCT07255638
What this trial is testing

A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany

Who this might be right for
Indolent Systemic Mastocytosis
Blueprint Medicines Corporation 80
Testing effectiveness (Phase 2)UnknownNCT01920204
What this trial is testing

Midostaurin in Indolent Systemic Mastocytosis

Who this might be right for
Indolent Systemic Mastocytosis
University Medical Center Groningen 20
Large-scale testing (Phase 3)Looking for participantsNCT04910685
What this trial is testing

(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

Who this might be right for
Indolent Systemic MastocytosisSmoldering Systemic Mastocytosis
Blueprint Medicines Corporation 534
Very early researchLooking for participantsNCT05043701
What this trial is testing

Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Oslo University Hospital 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03731260
What this trial is testing

(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis

Who this might be right for
Indolent Systemic Mastocytosis
Blueprint Medicines Corporation 251
Early research (Phase 1)Study completedNCT02808793
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002

Who this might be right for
Indolent Systemic Mastocytosis
Allakos Inc. 25
Large-scale testing (Phase 3)UnknownNCT04333108
What this trial is testing

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment

Who this might be right for
Indolent Systemic Mastocytosis
AB Science 140
Not applicableNot Yet RecruitingNCT07264959
What this trial is testing

An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)

Who this might be right for
Indolent Systemic Mastocytosis
Blueprint Medicines Corporation 150
Large-scale testing (Phase 3)Study completedNCT03870880
What this trial is testing

Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension

Who this might be right for
Schizophrenia
Rovi Pharmaceuticals Laboratories 215
Early research (Phase 1)Study completedNCT01320410
What this trial is testing

Pharmacokinetics, Safety, and Tolerance Study of Single Dose Administration of Risperidone ISM®

Who this might be right for
Healthy
Rovi Pharmaceuticals Laboratories
Testing effectiveness (Phase 2)Active Not RecruitingNCT05186753
What this trial is testing

(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis

Who this might be right for
SSMMastocytosis, IndolentMastocytosis, Systemic+5 more
Cogent Biosciences, Inc. 237
Early research (Phase 1)Study completedNCT05179525
What this trial is testing

Comparative Bioavailability of Risperidone.

Who this might be right for
Schizophrenia
Rovi Pharmaceuticals Laboratories 80
Early research (Phase 1)Study completedNCT01788774
What this trial is testing

Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths

Who this might be right for
SchizophreniaSchizoaffective Disorder
Rovi Pharmaceuticals Laboratories 36
Not applicableUnknownNCT05923372
What this trial is testing

Evaluation of the DALY on a Cohort of Patients With Indolent Systemic Mastocytosis

Who this might be right for
Mastocytosis, Indolent Systemic
University Hospital, Toulouse 160
Post-approval studies (Phase 4)Ended earlyNCT01033565
What this trial is testing

Melatonin CR for the Treatment of Impaired Sleep Maintenance in 4-8 Year Old Children With Autism Spectrum Disorders

Who this might be right for
Sleep Disorder
University of Nebraska 1
Not applicableStudy completedNCT07335549
What this trial is testing

Istmin Levels in Laparoscopik Sleeve Gastrectomy

Who this might be right for
Obesity & OverweightSleeve GastrectomyAdipokines
Saglik Bilimleri Universitesi 40
Testing effectiveness (Phase 2)Study completedNCT02086786
What this trial is testing

Pharmacokinetics and Tolerability Study of Risperidone ISM® in Schizophrenia

Who this might be right for
Schizophrenia
Rovi Pharmaceuticals Laboratories 70
Early research (Phase 1)Study completedNCT03527186
What this trial is testing

Comparative Bioavailability of Risperidone

Who this might be right for
Schizophrenia
Rovi Pharmaceuticals Laboratories 81
Large-scale testing (Phase 3)Study completedNCT03160521
What this trial is testing

Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle (ISM)® in Patients With Acute Schizophrenia

Who this might be right for
Acute Schizophrenia
Rovi Pharmaceuticals Laboratories 438
Load More Results